Lipodystrophy and antiretroviral agents
Martínez, E.; Gatell, J.M.
Revista Clinica Espanola 199(8): 485-486
1999
ISSN/ISBN: 0014-2565 PMID: 10522426 Document Number: 509833
Document emailed within 1 workday
Related Documents
Parakh, A.; Dubey, A.P.; Kumar, A.; Maheshwari, A. 2009: Lipodystrophy and metabolic complications of highly active antiretroviral therapy Indian Journal of Pediatrics 76(10): 1017-1021Sangraula, H.; Sharma, K.K.; Dwivedi, S. 2001: Antiretroviral protease inhibitor therapy leads to hyperglycaemia, hyperlipidaemia and lipodystrophy National Medical Journal of India 14(6): 347-348
Brambilla, P.; Bricalli, D.; Sala, N.; Renzetti, F.; Manzoni, P.; Vanzulli, A.; Chiumello, G.; di Natale, B.; Viganò, A. 2001: Highly active antiretroviral-treated HIV-infected children show fat distribution changes even in absence of lipodystrophy Aids 15(18): 2415-2422
Lapphra, K.; Vanprapar, N.; Phongsamart, W.; Chearskul, P.; Chokephaibulkit, K. 2005: Dyslipidemia and lipodystrophy in HIV-infected Thai children on highly active antiretroviral therapy (HAART) Journal of the Medical Association of Thailand 88(7): 956-966
Chuapai, Y.; Kiertiburanakul, S.; Malathum, K.; Sungkanuparph, S. 2007: Lipodystrophy and dyslipidemia in human immunodeficiency virus-infected Thai patients receiving antiretroviral therapy Journal of the Medical Association of Thailand 90(3): 452-458
Mercier, S.; Gueye, N.F.N.; Cournil, A.; Fontbonne, A.; Copin, N.; Ndiaye, I.; Dupuy, A.-M.; Cames, C.éc.; Sow, P.S.; Ndoye, I.; Delaporte, E.; Simondon, K.B. 2009: Lipodystrophy and metabolic disorders in HIV-1-infected adults on 4- to 9-year antiretroviral therapy in Senegal: a case-control study Journal of Acquired Immune Deficiency Syndromes 51(2): 224-230
Piloya, T.; Bakeera-Kitaka, S.; Kekitiinwa, A.; Kamya, M.R. 2012: Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study Journal of the International Aids Society 15(2): 17427
Werner, M.L.F.; Pone, M.V.d.S.; Fonseca, V.ân.M.; Chaves, C.él.R.M.d.M. 2010: Lipodystrophy syndrome and cardiovascular risk factors in children and adolescents infected with HIV/AIDS receiving highly active antiretroviral therapy Jornal de Pediatria 86(1): 27-32
Werner, M.L.F.; Pone, M.V.d.S.; Fonseca, V.ân.M.; Chaves, C.él.R.M.d.M. 2010: Lipodystrophy syndrome and cardiovascular risk factors in children and adolescents infected with HIV/AIDS receiving highly active antiretroviral therapy Jornal de Pediatria 86(1): 27-32
Han, S.H.; Zhou, J.; Saghayam, S.; Vanar, S.; Phanuphak, N.; Chen, Y.-M.A.; Sirisanthana, T.; Sungkanuparph, S.; Lee, C.K.C.; Pujari, S.; Li, P.C.K.; Oka, S.; Saphonn, V.; Zhang, F.; Merati, T.P.; Law, M.G.; Choi, J.Y.; Mean, C.V.; Saphonn, V.; Vohith, K.; Zhang, F.J.; Zhao, H.X.; Han, N.; Li, P.C.K.; Lee, M.P.; Kumarasamy, N.; Saghayam, S.; Pujari, S.; Joshi, K.; Merati, T.P.; Yuliana, F.; Yunihastuti, E.; Ramadian, O.; Oka, S.; Honda, M.; Choi, J.Y.; Han, S.H.; Lee, C.K.C.; David, R.; Kamarulzaman, A.; Kajindran, A.; Tau, G.; Ditangco, R.; Capistrano, R.; Wong, W.W.; Yang, Y.W.; Lim, P.L.; Ng, O.T.; Foo, E.; Phanuphak, P.; Khongphattanayothin, M.; Sungkanuparph, S.; Kiertiburanakul, S.; Piyavong, B.; Sirisanthana, T.; Kotarathititum, W.;, 2011: Prevalence of and risk factors for lipodystrophy among HIV-infected patients receiving combined antiretroviral treatment in the Asia-Pacific region: results from the TREAT Asia HIV Observational Database (TAHOD) Endocrine Journal 58(6): 475-484
Roca, B.; Simón, E. 1998: New antiretroviral agents Anales de Medicina Interna 15(11): 606-614
Lange, J.M.A.; Ananworanich, J. 2014: The discovery and development of antiretroviral agents Antiviral Therapy 19 Suppl. 3: 5-14
Engebretsen, I.M.S.; Tylleskär, T. 2010: HIV, breast feeding and antiretroviral agents Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 130(5): 520-522
Buss, N.; Cammack, N. 2001: Measuring the effectiveness of antiretroviral agents Antiviral Therapy 6(1): 1-7
Horsmans, Y.; Larrey, D.; Pessayre, D.; Benhamou, J.P. 1990: Hepatotoxicity of antimicrobial agents. II: Urinary antiseptics, antitubercular agents, antiparasitic agents, antifungal agents, antiviral agents Gastroenterologie Clinique et Biologique 14(12): 919-924
Martins, C.R. 2006: Cutaneous drug reactions associated with newer antiretroviral agents Journal of Drugs in Dermatology: Jdd 5(10): 976-982
Groopman, J.E. 1991: Treatment of AIDS with combinations of antiretroviral agents: a summary American Journal of Medicine 90(4a): 27S-30S
Burger, D.M.; Hoetelmans, R.M.; Koopmans, P.P.; Meenhorst, P.L.; Mulder, J.W.; Hekster, Y.A.; Beijnen, J.H. 1997: Clinically relevant drug interactions with antiretroviral agents Antiviral Therapy 2(3): 149-165
Acosta, E.P.; Gerber, J.G. 2002: Position paper on therapeutic drug monitoring of antiretroviral agents AIDS research and human retroviruses 18(12): 825-834
El-Beitune, P.; Duarte, G.; de Morais, E.N.; Campbell, O.; Spara-Gadelha, P.; Mauad-Filho, F.; Quintana, S.M.; Rodrigues, L.C. 2007: Antiretroviral agents and acid-base balance at delivery of the neonate Brazilian Journal of Medical and Biological Research 40(7): 957-961